Cyrill Wehling

423 total citations
13 papers, 278 citations indexed

About

Cyrill Wehling is a scholar working on Surgery, Immunology and Epidemiology. According to data from OpenAlex, Cyrill Wehling has authored 13 papers receiving a total of 278 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Surgery, 5 papers in Immunology and 4 papers in Epidemiology. Recurrent topics in Cyrill Wehling's work include Liver Disease and Transplantation (4 papers), Complement system in diseases (4 papers) and Renal Diseases and Glomerulopathies (3 papers). Cyrill Wehling is often cited by papers focused on Liver Disease and Transplantation (4 papers), Complement system in diseases (4 papers) and Renal Diseases and Glomerulopathies (3 papers). Cyrill Wehling collaborates with scholars based in Germany, United States and Switzerland. Cyrill Wehling's co-authors include Michael Kirschfink, Karim Kentouche, Annika Gauss, Johannes Krisam, Péter Hoffmann, Gesa Schalk, Bernd Höppe, Petra Kloeters-Plachky, Carsten Bergmann and Burkhard Tönshoff and has published in prestigious journals such as World Journal of Gastroenterology, Psychiatric Services and Nephrology Dialysis Transplantation.

In The Last Decade

Cyrill Wehling

12 papers receiving 264 citations

Peers

Cyrill Wehling

IMMUN

NEPHR

EPIDE

HEMAT

GENET

Deborah Weber Canada

D. Cornet France

Tatjana Jeren Croatia

JEROME L. KOHN United States

B.‐M. Svahn Sweden

Renise Ayearst Canada

Arie Koifman Israel

Maria Ibarra United States

Morgan Similuk United States

Vicki Santos United States

Deborah Weber Canada

Cyrill Wehling

123 ×0.9

IMMUN

7 ×0.1

NEPHR

49 ×0.9

EPIDE

31 ×0.6

HEMAT

34 ×0.7

GENET

Citations per year, relative to Cyrill Wehling Cyrill Wehling (= 1×) peers Deborah Weber

Countries citing papers authored by Cyrill Wehling

Since Specialization

Citations

This map shows the geographic impact of Cyrill Wehling's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cyrill Wehling with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cyrill Wehling more than expected).

Fields of papers citing papers by Cyrill Wehling

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cyrill Wehling. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cyrill Wehling. The network helps show where Cyrill Wehling may publish in the future.

Co-authorship network of co-authors of Cyrill Wehling

This figure shows the co-authorship network connecting the top 25 collaborators of Cyrill Wehling. A scholar is included among the top collaborators of Cyrill Wehling based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cyrill Wehling. Cyrill Wehling is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Koschny, Ronald, Patrick Michl, Arianeb Mehrabi, et al.. (2025). Post-endoscopic retrograde cholangiopancreatography cholangitis after endoscopic treatment of post-transplant biliary strictures: a retrospective study. BMC Surgery. 25(1). 353–353.

Olkus, Alexander, Aurelie Tomczak, Anne Berger, et al.. (2024). Durvalumab Plus Gemcitabine and Cisplatin in Patients with Advanced Biliary Tract Cancer: An Exploratory Analysis of Real-World Data. Targeted Oncology. 19(2). 213–221. 9 indexed citations

Wehling, Cyrill, Michael T. Dill, Alexander Olkus, et al.. (2021). Treatment stage migration and treatment sequences in patients with hepatocellular carcinoma: drawbacks and opportunities. Journal of Cancer Research and Clinical Oncology. 147(8). 2471–2481. 7 indexed citations

Hornuß, Daniel, Lucas J. Koerner, Isabelle Mohr, et al.. (2021). HBV-infection rate and long-term outcome after liver-transplantation of anti-HBc-positive liver-grafts to HBV-naïve recipients: A retrospective study. Clinics and Research in Hepatology and Gastroenterology. 45(2). 101496–101496. 2 indexed citations

Pfeiffenberger, Jan, Daniel Hornuß, Cyrill Wehling, et al.. (2019). Routine Liver Elastography Could Predict Actuarial Survival after Liver Transplantation. Journal of Gastrointestinal and Liver Diseases. 28(3). 271–277. 6 indexed citations

Hoffmann, Péter, et al.. (2019). Performance of tacrolimus in hospitalized patients with steroid-refractory acute severe ulcerative colitis. World Journal of Gastroenterology. 25(13). 1603–1617. 19 indexed citations

Hoffmann, Péter, et al.. (2019). Ustekinumab: “Real-world” outcomes and potential predictors of nonresponse in treatment-refractory Crohn’s disease. World Journal of Gastroenterology. 25(31). 4481–4492. 35 indexed citations

Wehling, Cyrill, Daniel Hornuß, Christoph Springfeld, et al.. (2019). Impact of interventions and tumor stage on health-related quality of life in patients with hepatocellular carcinoma. Journal of Cancer Research and Clinical Oncology. 145(11). 2761–2769. 5 indexed citations

Riedemann, Niels C., et al.. (2017). Controlling the anaphylatoxin C5a in diseases requires a specifically targeted inhibition. Clinical Immunology. 180. 25–32. 34 indexed citations

10.

Ahlenstiel-Grunow, Thurid, et al.. (2016). Systemic complement activation and complement gene analysis in enterohaemorrhagicEscherichia coli-associated paediatric haemolytic uraemic syndrome. Nephrology Dialysis Transplantation. 31(7). 1114–1121. 21 indexed citations

11.

Wehling, Cyrill, Oliver Amon, Martin Bommer, et al.. (2016). Monitoring of complement activation biomarkers and eculizumab in complement-mediated renal disorders. Clinical & Experimental Immunology. 187(2). 304–315. 74 indexed citations

12.

Schalk, Gesa, Michael Kirschfink, Cyrill Wehling, et al.. (2015). A complicated case of atypical hemolytic uremic syndrome with frequent relapses under eculizumab. Pediatric Nephrology. 30(6). 1039–1042. 13 indexed citations

13.

Wehling, Cyrill, et al.. (1987). Group Art Therapy as an Adjunct to Treatment for Chronic Outpatients. Psychiatric Services. 38(9). 988–991. 53 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact